| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $43.3M | +25.0% |
| Cost of Revenue | $37.3M | +35.3% |
| R&D Expense | $85K | -72.8% |
| SG&A Expense | $5.4M | +64.3% |
| Operating Income | -$5.0M | -173.1% |
| Interest Expense | $2.2M | -51.9% |
| Pre-tax Income | -$14.7M | -110.7% |
| Income Tax | $55K | — |
| Net Income | -$14.7M |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.4M | -59.4% |
| Accounts Receivable | $6.0M | -12.4% |
| Current Assets | $8.6M | -25.1% |
| Total Assets | $24.1M | -14.5% |
| Current Liabilities | $7.7M | -63.5% |
| Total Liabilities | $7.8M | -63.1% |
| Stockholders' Equity | $16.3M | +129.5% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.2M | +147.1% |
| Capital Expenditures | $318K | +45.2% |
| Investing Cash Flow | -$1.3M | -506.4% |
| Financing Cash Flow | -$3.0M | -140.7% |
| Free Cash Flow | $1.9M | +138.5% |
| -111.5% |
| EPS (Basic) | -$0.68 | -1033.3% |